Search

Search Constraints

You searched for: Author/Creator Algaba, Alicia

Search Results

1. Association of golimumab trough concentrations during maintenance with clinical, biological, endoscopic and histologic remission in patients with ulcerative colitis. Issue 4 (4th May 2022)

2. Clinical features, therapeutic requirements and evolution of patients with Crohn's disease and upper gastrointestinal involvement (CROHNEX study). Issue 8 (18th August 2021)

3. Clinical features, therapeutic requirements and evolution of patients with Crohn's disease and upper gastrointestinal involvement (CROHNEX study). Issue 8 (18th August 2021)

4. Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis. Issue 8 (30th June 2017)

5. Corrigendum to: Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy. Issue 1 (12th October 2021)

6. Corrigendum to: Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy. Issue 1 (5th January 2022)

7. Early dose optimization of golimumab induces late response and long-term clinical benefit in moderately to severely active ulcerative colitis. (3rd July 2019)

8. Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry. (16th April 2021)

9. Evaluation of the Quality of Semen and Sexual Function in Men with Inflammatory Bowel Disease. Issue 7 (16th May 2017)

10. Evaluation of the Quality of Semen and Sexual Function in Men with Inflammatory Bowel Disease. Issue 7 (July 2017)